REGULATION OF FAS MEDIATED APOPTOSIS IN EOSINOPHILS

FAS 介导的嗜酸性粒细胞细胞凋亡的调节

基本信息

  • 批准号:
    2802434
  • 负责人:
  • 金额:
    $ 12.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-08-01 至 1999-07-31
  • 项目状态:
    已结题

项目摘要

Studies are proposed to examine the mechanisms and consequences of Fas- mediated apoptosis of human eosinophils. The central, underling hypothesis for these studies is that Fas-induced killing of eosinophils represents a natural mechanism for inflammatory resolution which normally is regulated by specific extracellular and intracellular mechanisms. To test this hypothesis, we propose three specific areas of study: (1) Fas-induced apoptosis in eosinophils. a) The expression and regulation of Fas and Fas- induced apoptosis of human eosinophils by TNF-alpha and IFN-gamma will be studied using RT-PCR and flow cytometric assays and specific analyses of eosinophil apoptosis; b) The regulation of Fas expression by aminopeptidase N/CD13 will be examined using specific anti-CD13 blocking antibodies and aminopeptidase and other inhibitors; c) Intracellular expression of Bcl-2 related and ICE family mRNA and proteins in susceptible and resistant eosinophil populations, using RT-PCR, Northern, Western and flow cytometric assays to clarify specific intracellular mechanisms of regulation of Fas-induced apoptosis. (2) Fas-Fas ligand interactions between eosinophils and airway epithelial cells. a) The expression of Fas ligand similar to those for studying Fas expression of eosinophils including RT-PCR and Norther analyses of specific interaction will be examined in "co-cultures" of eosinophils and epithelial monolayers; c) Metalloprotease inhibitors will be tested for effects on FasL expression. (3) Fas-Fas ligand interactions and eosinophil bioactivity. a) The activation of NF-kappaB in Fas-susceptible and Fas- resistant cells will be assessed using electromobility shift assays and supershift assays of nuclear extracts from these cells; b) The expression of NF-kappaB inducible cytokine genes and their protein products by Fas- induced eosinophils will be studied by Northern, Western and ELISA analyses in order to determine the potential for autocrine, juxtacrine and/or paracrine interactions with pulmonary tissues and cells; c) The release of cytoactive granule proteins, MBP and EPO, by apoptotic versus necrotic versus de-granulating eosinophils will be assessed by protein- specific assays. These studies should elucidate critical mechanisms regulated Ras-mediated apoptosis and determine potential in vivo effects of pharmacologic or physiologic induction of this apoptosis of eosinophils.
建议研究Fas的机制和后果, 介导的人嗜酸性粒细胞凋亡。核心的,基础的假设 Fas诱导的嗜酸性粒细胞的杀伤代表了一种 炎症消退的天然机制,通常是受调节的 通过特定的细胞外和细胞内机制。为了验证这一 假设,我们提出了三个具体的研究领域:(1)Fas诱导的 嗜酸性粒细胞凋亡。a)Fas和Fas的表达和调节- TNF-α和IFN-γ诱导的人嗜酸性粒细胞凋亡将是 使用RT-PCR和流式细胞术分析以及 B)Fas表达的调节 将使用特异性抗CD 13阻断剂检测氨肽酶N/CD 13 抗体和氨肽酶及其他抑制剂; c)细胞内 Bcl-2相关基因和ICE家族mRNA及蛋白表达 使用RT-PCR,北方, Western和流式细胞术分析,以澄清特定的细胞内 Fas诱导细胞凋亡的调控机制。(2)Fas-Fas配体 嗜酸性粒细胞和气道上皮细胞之间的相互作用。(一) Fas配体的表达类似于研究Fas表达的那些。 嗜酸性粒细胞,包括特异性相互作用的RT-PCR和Norther分析 将在嗜酸性粒细胞和上皮细胞的“共培养物”中进行检查 c)将测试金属蛋白酶抑制剂对细胞单层的影响。 FasL表达。(3)Fas-Fas配体相互作用与嗜酸性粒细胞 生物活性a)Fas-敏感和Fas-不敏感细胞中NF-κ B的活化。 将使用电迁移率变动测定来评估抗性细胞, 来自这些细胞的核提取物的超移位测定; B)表达 NF-κ B诱导的细胞因子基因及其蛋白产物的Fas- 将通过北方、西方和ELISA研究诱导的嗜酸性粒细胞 分析,以确定自分泌的可能性, 和/或与肺组织和细胞的旁分泌相互作用; 细胞凋亡与细胞凋亡引起的细胞活性颗粒蛋白MBP和EPO的释放, 将通过蛋白质- 具体分析。这些研究应阐明关键机制 调节Ras介导的细胞凋亡,并确定潜在的体内效应 药理学或生理学诱导这种细胞凋亡, 嗜酸性粒细胞

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KIMM J HAMANN其他文献

KIMM J HAMANN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KIMM J HAMANN', 18)}}的其他基金

Mechanisms of Hypothermic Protection from Ischemia/Reperfusion Cardiac Injury
低温保护缺血/再灌注心脏损伤的机制
  • 批准号:
    7475785
  • 财政年份:
    2007
  • 资助金额:
    $ 12.71万
  • 项目类别:
Mechanisms of Hypothermic Protection from Ischemia/Reperfusion Cardiac Injury
低温保护缺血/再灌注心脏损伤的机制
  • 批准号:
    7885246
  • 财政年份:
    2007
  • 资助金额:
    $ 12.71万
  • 项目类别:
Mechanisms of Hypothermic Protection from Ischemia/Reperfusion Cardiac Injury
低温保护缺血/再灌注心脏损伤的机制
  • 批准号:
    7659660
  • 财政年份:
    2007
  • 资助金额:
    $ 12.71万
  • 项目类别:
Mechanisms of Hypothermic Protection from Ischemia/Reperfusion Cardiac Injury
低温保护缺血/再灌注心脏损伤的机制
  • 批准号:
    7323619
  • 财政年份:
    2007
  • 资助金额:
    $ 12.71万
  • 项目类别:
Oxidants & Caspases: Initiation of Reperfusion Injury
氧化剂
  • 批准号:
    7332186
  • 财政年份:
    2005
  • 资助金额:
    $ 12.71万
  • 项目类别:
Oxidants & Caspases: Initiation of Reperfusion Injury
氧化剂
  • 批准号:
    7564093
  • 财政年份:
    2005
  • 资助金额:
    $ 12.71万
  • 项目类别:
Oxidants & Caspases: Initiation of Reperfusion Injury
氧化剂
  • 批准号:
    7174302
  • 财政年份:
    2005
  • 资助金额:
    $ 12.71万
  • 项目类别:
Oxidants & Caspases: Initiation of Reperfusion Injury
氧化剂
  • 批准号:
    7006058
  • 财政年份:
    2005
  • 资助金额:
    $ 12.71万
  • 项目类别:
Oxidants & Caspases: Initiation of Reperfusion Injury
氧化剂
  • 批准号:
    6875993
  • 财政年份:
    2005
  • 资助金额:
    $ 12.71万
  • 项目类别:
Eosinophil-Airway Epithelial Fas-FasL Interactions
嗜酸性粒细胞-气道上皮 Fas-FasL 相互作用
  • 批准号:
    6383514
  • 财政年份:
    2001
  • 资助金额:
    $ 12.71万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了